CPT Codes Mapped to CVX Codes

 

This table cross-references Current Procedural Terminology (CPT™) codes that are related to vaccines, toxoids and immune globulins with their corresponding CVX codes.

Available Printable versions:   Excel format Pdf format Flat file XML format 

Sort Table by Column: Simply click on the column heading to sort the table accordingly.

The Last Updated column indicates the last time this particular CPT code was updated in this table.

CPT CODE	CPT Description	CVX Code	Vaccine Name	Comments	Last Updated Date
90281	Immune globulin (IG), human, for intramuscular use	86	IG		5/28/2010
90283	Immune globulin (IGIV), human, for intravenous use	87	IGIV		5/28/2010
90287	Botulinum antitoxin, equine, any route	27	botulinum antitoxin		5/28/2010
90291	Cytomegalovirus immune globulin (CMV-IGIV), human, for intravenous use	29	CMVIG		5/28/2010
90296	Diphtheria antitoxin, equine, any route	12	diphtheria antitoxin		5/28/2010
90371	Hepatitis B immune globulin (HBIG), human, for intramuscular use	30	HBIG		5/28/2010
90375	Rabies immune globulin (RIG), human, for intramuscular and/or subcutaneous use	34	RIG		5/28/2010
90376	Rabies immune globulin, heat-treated (RIG-HT), human, for intramuscular and/or subcutaneous use	34	RIG		5/28/2010
90378	Respiratory syncytial virus immune globulin (RSV-IgIM), for intramuscular use, 50 mg, each	93	RSV-MAb		5/28/2010
90379	Respiratory syncytial virus immune globulin (RSV-IGIV), human, for intravenous use	71	RSV-IGIV		5/28/2010
90389	Tetanus immune globulin (TIG), human, for intramuscular use	13	TIG		5/28/2010
90393	Vaccinia immune globulin, human, for intramuscular use	79	vaccinia immune globulin		5/28/2010
90396	Varicella-zoster immune globulin, human, for intramuscular use	36	VZIG		5/28/2010
90470	H1N1 immunization administration (intramuscular, intranasal), including counseling when performed	128	Novel Influenza-H1N1-09, all formulations		8/31/2010
90476	Adenovirus vaccine, type 4, live, for oral use	54	adenovirus, type 4		5/28/2010
90477	Adenovirus vaccine, type 7, live, for oral use	55	adenovirus, type 7		5/28/2010
90581	Anthrax vaccine, for subcutaneous use	24	anthrax		5/28/2010
90585	Bacillus Calmette-Guerin vaccine (BCG) for tuberculosis, live, for percutaneous use	19	BCG		5/28/2010
90620	Meningococcal recombinant protein and outer membrane vesicle vaccine, serogroup B, 2 dose schedule, for intramuscular	163	meningococcal B, OMV		2/20/2015
90621	Meningococcal recombinant lipoprotein vaccine, serogroup B, 3 dose schedule, for intramuscular use	162	meningococcal B, recombinant		11/6/2014
90625	Cholera vaccine live, adult dosage, 1 dose schedule, for oral use	174	cholera, live attenuated		8/24/2016
90630	Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, for intradermal use	166	influenza, intradermal, quadrivalent, preservative free		1/9/2015
90632	Hepatitis A vaccine, adult dosage, for intramuscular use	52	Hep A, adult		5/28/2010
90633	Hepatitis A vaccine, pediatric/adolescent dosage-2 dose schedule, for intramuscular use	83	Hep A, ped/adol, 2 dose		5/28/2010
90634	Hepatitis A vaccine, pediatric/adolescent dosage-3 dose schedule, for intramuscular use	84	Hep A, ped/adol, 3 dose		5/28/2010
90636	Hepatitis A and hepatitis B (HepA-HepB), adult dosage, for intramuscular use	104	Hep A-Hep B		5/28/2010
90644	Meningococcal conjugate vaccine, serogroups C amp; Y and Hemophilus influenza B vaccine (MenCY-Hib)	148	Meningococcal C/Y-HIB PRP		1/9/2015
90645	Haemophilus influenza b vaccine (Hib), HbOC conjugate (4 dose schedule), for intramuscular use	47	Hib (HbOC)		5/28/2010
90646	Haemophilus influenza b vaccine (Hib), PRP-D conjugate, for booster use only, intramuscular use	46	Hib (PRP-D)		5/28/2010
90647	Haemophilus influenza b vaccine (Hib), PRP-OMP conjugate (3 dose schedule), for intramuscular use	49	Hib (PRP-OMP)		5/28/2010
90648	Haemophilus influenza b vaccine (Hib), PRP-T conjugate (4 dose schedule), for intramuscular use	48	Hib (PRP-T)		5/28/2010
90649	Human Papilloma virus (HPV) vaccine, types 6, 11, 16, 18 (quadrivalent) 3 dose schedule, for intramuscular use	62	HPV, quadrivalent		5/28/2010
90650	Human Papilloma virus (HPV) vaccine, types 16, 18, bivalent, 3 dose schedule, for intramuscular use	118	HPV, bivalent		5/28/2010
90651	Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (HPV)	165	HPV9		1/9/2015
90653	Influenza virus vaccine, inactivated, subunit, adjuvanted for IM us	168	influenza, trivalent, adjuvanted		4/25/2016
90654	Influenza virus vaccine, split virus, preservative free, for intradermal use	144	influenza, seasonal, intradermal, preservative free		8/1/2012
90655	Influenza virus vaccine, trivalent, split virus, preservative free, for children 6-35 months of age, for intramuscular use	140	Influenza, seasonal, injectable, preservative free		4/25/2016
90656	Influenza virus vaccine, trivalent, split virus, preservative free, for use in individuals 3 years of age and above, for intramuscular use	140	Influenza, seasonal, injectable, preservative free		4/25/2016
90657	Influenza virus vaccine, trivalent, split virus, for children 6-35 months of age, for intramuscular use	141	Influenza, seasonal, injectable		4/25/2016
90658	Influenza virus vaccine,trivalent, split virus, for use in individuals 3 years of age and above, for intramuscular use	141	Influenza, seasonal, injectable		4/25/2016
90659	Influenza virus vaccine, whole virus, for intramuscular or jet injection use	16	influenza, whole		3/17/2011
90660	Influenza virus vaccine, trivalent, live, for intranasal use	111	influenza, live, intranasal		4/25/2016
90661	Influenza virus vaccine, derived from cell cultures, subunit, preservative and antibiotic free, for intramuscular use	153	Influenza, injectable, MDCK, preservative free		9/5/2013
90662	Influenza virus vaccine, split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use	135	Influenza, high dose seasonal		5/28/2010
90663	Influenza virus vaccine, pandemic formulation, H1N1	128	Novel Influenza-H1N1-09, all formulations		8/31/2010
90664	Influenza virus vaccine, pandemic formulation, live, for intranasal use	125	Novel Influenza-H1N1-09, nasal		8/31/2010
90665	Lyme disease vaccine, adult dosage, for intramuscular use	66	Lyme disease		4/25/2016
90666	Influenza virus vaccine, pandemic formulation, split-virus, preservative free, for intramuscular use	126	Novel influenza-H1N1-09, preservative-free		8/31/2010
90668	Influenza virus vaccine, pandemic formulation, split-virus, for intramuscular use	127	Novel influenza-H1N1-09		8/31/2010
90669	Pneumococcal conjugate vaccine, polyvalent, for children under five years, for intramuscular use	100	pneumococcal conjugate PCV 7		5/28/2010
90670	Pneumococcal conjugate vaccine, 13 valent, for intramuscular use	133	Pneumococcal conjugate PCV 13		5/28/2010
90672	Influenza virus vaccine, quadrivalent (LAIV), live, intranasal use	149	influenza, live, intranasal, quadrivalent		4/25/2016
90673	Influenza virus vaccine, trivalent, derived from recombinant DNA (RIV3), hemagglutnin (HA) protein only, preservative and antibiotic free, for intramuscular use	155	influenza, recombinant, injectable, preservative free		8/21/2013
90674	Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use	171	Influenza, injectable, MDCK, preservative free, quadrivalent		6/29/2016
90675	Rabies vaccine, for intramuscular use	175	Rabies - IM Diploid cell culture		11/22/2016
90675	Rabies vaccine, for intramuscular use	176	Rabies - IM fibroblast culture		11/22/2016
90675	Rabies vaccine, for intramuscular use	18	rabies, intramuscular injection		5/28/2010
90676	Rabies vaccine, for intradermal use	40	rabies, intradermal injection		5/28/2010
90680	Rotavirus vaccine, pentavalent, 3 dose schedule, live, for oral use	116	rotavirus, pentavalent		5/28/2010
90681	Rotavirus vaccine, human, attenuated, 2 dose schedule, live, for oral use	119	rotavirus, monovalent		5/28/2010
90685	Influenza virus vaccine, quadrivalent, split virus, preservative free, when administered to children 6-35 months of age, for intramuscular us	161	Influenza, injectable,quadrivalent, preservative free, pediatric		8/11/2014
90686	Influenza virus vaccine, quadrivalent, split virus, preservative free, when administered to individuals 3 years of age and older, for intramuscular use	150	influenza, injectable, quadrivalent, preservative free		1/3/2013
90687	Influenza virus vaccine, quadrivalent, split virus, when administered to children 6-35 months of age, for intramuscular use	158	influenza, injectable, quadrivalent		6/11/2014
90688	Influenza virus vaccine, quadrivalent, split virus, when administered to individuals 3 years of age and older, for intramuscular use	158	influenza, injectable, quadrivalent		1/3/2013
90690	Typhoid vaccine, live, oral	25	typhoid, oral		5/28/2010
90691	Typhoid vaccine, Vi capsular polysaccharide (ViCPs), for intramuscular use	101	typhoid, ViCPs		5/28/2010
90692	Typhoid vaccine, heat- and phenol-inactivated (H-P), for subcutaneous or intradermal use	41	typhoid, parenteral		5/28/2010
90693	Typhoid vaccine, acetone-killed, dried (AKD), for subcutaneous use (U.S. military)	53	typhoid, parenteral, AKD (U.S. military)		5/28/2010
90696	Diphtheria, tetanus toxoids, acellular pertussis vaccine and poliovirus vaccine, inactivated (DTaP-IPV), when administered to children 4 years through 6 years of age, for intramuscular use	130	DTaP-IPV		5/28/2010
90697	Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hib-HepB), for intramuscular use	146	DTaP,IPV,Hib,HepB		8/24/2016
90698	Diphtheria, tetanus toxoids, and acellular pertussis vaccine, haemophilus influenza Type B, and poliovirus vaccine, inactivated (DTaP - Hib - IPV), for intramuscular use	120	DTaP-Hib-IPV		5/28/2010
90700	Diphtheria, tetanus toxoids, and acellular pertussis vaccine (DTaP), for use in individuals younger than seven years, for intramuscular use	106	DTaP, 5 pertussis antigens		9/28/2010
90700	Diphtheria, tetanus toxoids, and acellular pertussis vaccine (DTaP), for use in individuals younger than seven years, for intramuscular use	20	DTaP		5/28/2010
90701	Diphtheria, tetanus toxoids, and whole cell pertussis vaccine (DTP), for intramuscular use	01	DTP		4/25/2016
90702	Diphtheria and tetanus toxoids (DT) adsorbed for use in individuals younger than seven years, for intramuscular use	28	DT (pediatric)		5/28/2010
90703	Tetanus toxoid adsorbed, for intramuscular use	35	tetanus toxoid, adsorbed		5/28/2010
90704	Mumps virus vaccine, live, for subcutaneous use	07	mumps		5/28/2010
90705	Measles virus vaccine, live, for subcutaneous use	05	measles		5/28/2010
90706	Rubella virus vaccine, live, for subcutaneous use	06	rubella		5/28/2010
90707	Measles, mumps and rubella virus vaccine (MMR), live, for subcutaneous use	03	MMR		5/28/2010
90708	Measles and rubella virus vaccine, live, for subcutaneous use	04	M/R		5/28/2010
90710	Measles, mumps, rubella, and varicella vaccine (MMRV), live, for subcutaneous use	94	MMRV		5/28/2010
90712	Poliovirus vaccine, (any type(s)) (OPV), live, for oral use	02	OPV		5/28/2010
90713	Poliovirus vaccine, inactivated, (IPV), for subcutaneous or intramuscular use	10	IPV		5/28/2010
90714	Tetanus and Diphtheria, adsorbed	09	Td (adult), adsorbed		12/12/2016
90714	Typhoid vaccine	91	typhoid, unspecified formulation	This cpt code has been reused for TD, preservative free.	3/17/2011
90714	Tetanus and diphtheria toxoids (Td) adsorbed, preservative free, for use in individuals seven years or older, for intramuscular use	113	Td (adult) preservative free	Beginning in 2005, this CPT code maps to TD preservative free.	5/28/2010
90715	Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), for use in individuals 7 years or older, for intramuscular use	115	Tdap		5/28/2010
90716	Varicella virus vaccine, live, for subcutaneous use	21	varicella		5/28/2010
90717	Yellow fever vaccine, live, for subcutaneous use	37	yellow fever		5/28/2010
90718	Tetanus and diphtheria toxoids (Td) adsorbed for use in individuals seven years or older, for intramuscular use	09	Td (adult), adsorbed		5/28/2010
90720	Diphtheria, tetanus toxoids, and whole cell pertussis vaccine and Hemophilus influenza B vaccine (DTP-Hib), for intramuscular use	22	DTP-Hib		5/28/2010
90721	Diphtheria, tetanus toxoids, and acellular pertussis vaccine and Hemophilus influenza B vaccine (DTaP-Hib), for intramuscular use	50	DTaP-Hib		5/28/2010
90723	Diphtheria, tetanus toxoids, acellular pertussis vaccine, Hepatitis B, and poliovirus vaccine, inactivated (DTaP-HepB-IPV), for intramuscular use	110	DTaP-Hep B-IPV		5/28/2010
90724	Influenza virus vaccine	88	influenza, unspecified formulation		3/17/2011
90725	Cholera vaccine for injectable use	26	cholera, unspecified formulation		5/28/2010
90726	Rabies vaccine	90	rabies, unspecified formulation		3/17/2011
90727	Plague vaccine, for intramuscular use	23	plague		5/28/2010
90728	BCG vaccine	19	BCG		3/17/2011
90730	Hepatitis A vaccine	85	Hep A, unspecified formulation		3/17/2011
90731	Hepatitis B vaccine	45	Hep B, unspecified formulation		3/17/2011
90732	Pneumococcal polysaccharide vaccine, 23-valent, adult or immunosuppressed patient dosage, for use in individuals 2 years or older, for subcutaneous or intramuscular use	33	pneumococcal polysaccharide PPV23		5/28/2010
90733	Meningococcal polysaccharide vaccine (any group(s)), for subcutaneous use	32	meningococcal MPSV4		5/28/2010
90734	Meningococcal conjugate vaccine, serogroups A, C, Y and W-135 (tetravalent), for intramuscular use	114	meningococcal MCV4P	This CPT maps to 2 vaccines (MCV4P and MCV4O)	5/28/2010
90734	Meningococcal conjugate vaccine, serogroups A, C, Y and W-135 (tetravalent), for intramuscular use	136	Meningococcal MCV4O	This CPT maps to 2 vaccines (MCV4P and MCV4O)	5/28/2010
90735	Japanese encephalitis virus vaccine, for subcutaneous use	39	Japanese encephalitis SC		5/28/2010
90736	Zoster (shingles) vaccine, live, for subcutaneous injection	121	zoster		5/28/2010
90737	Hemophilus influenza B	17	Hib, unspecified formulation		3/17/2011
90738	Japanese encephalitis virus vaccine, inactivated, for intramuscular use	134	Japanese Encephalitis IM		5/28/2010
90739	Hepatitis B, adult dosage (2 dose schedule), for intramuscular use	43	Hep B, adult		4/25/2016
90740	Hepatitis B vaccine, dialysis or immunosuppressed patient dosage (3 dose schedule), for intramuscular use	44	Hep B, dialysis		5/28/2010
90741	Immunization, passive; immune serum globulin, human (ISG)	14	IG, unspecified formulation		3/17/2011
90743	Hepatitis B vaccine, adolescent (2 dose schedule), for intramuscular use	43	Hep B, adult		5/28/2010
90744	Hepatitis B vaccine, pediatric/adolescent dosage (3 dose schedule), for intramuscular use	08	Hep B, adolescent or pediatric		5/28/2010
90745	Hepatitis B vaccine, adolescent/high risk infant dosage, for intramuscular use	42	Hep B, adolescent/high risk infant		3/17/2011
90746	Hepatitis B vaccine, adult dosage, for intramuscular use	43	Hep B, adult		5/28/2010
90747	Hepatitis B vaccine, dialysis or immunosuppressed patient dosage (4 dose schedule), for intramuscular use	44	Hep B, dialysis		5/28/2010
90748	Hepatitis B and Hemophilus influenza b vaccine (HepB-Hib), for intramuscular use	51	Hib-Hep B		5/28/2010

 Top of Page

---

CPT codes are developed and maintained by the American Medical Association and are intended to support billing for services. CPT codes have been reproduced here with permission from the American Medical Association (AMA). CPT five-digit codes, nomenclature and other data are Copyright, American Medical Association. All Rights Reserved. No fee schedules, basic units, relative values or related listings are included in this cross-reference. The AMA assumes no liability for the data contained herein. Applicable FARS/DFARS restrictions apply to government use.

CVX codes are codes that indicate the product used in a vaccination. They are maintained by the Centers for Disease Control and Prevention, Immunization Information System Support Branch (IISSB) for use in HL7 data transmission.

The goal of the table is to support mapping of CPT codes to CVX codes. It is not intended to support mapping from CVX to CPT nor to be a definitive source for CPT codes. Active CPT codes, inactive CPT codes and pre-release CPT codes are included. Every effort is made to keep the codes current.

Questions regarding this table should be directed to the IIS Technical Assistance Team; CDC, National Centers for Immunization and Respiratory Diseases, Immunization Information Systems Support Branch-Informatics, 1600 Clifton Road, Mailstop E-62, Atlanta, GA 30333.

For further information on HL7 immunization data exchange and the CVX code set, contact the IIS Technical Assistance Team at: